Implant Sciences Corporation
Implant Sciences Corporation (IMSC:OTCBB) develops and commercializes explosives trace detection (ETD) solutions for transportation, critical infrastructure, and ports and borders security, as well as force protection and emergency response.Founded in 1984, Implant Sciences has a rich history of developing leading technologies in several markets including: ion implantation services for the semiconductor industry; brachytherapy seeds for prostate cancer treatment; and sophisticated coatings to reduce wear on orthopedic joint replacements.
By the end of 2008, as part of the company’s restructuring towards a single business focus, the medical and semiconductor businesses and associated assets were fully divested. The company today is a pure play in global Security, Safety, and Defense (SS&D) markets.
Contact Details
Office Address
Implant Sciences Corporation
600 Research Drive
Wilmington, MA, USA 01887
Phone: (978) 752-1700
Fax: (978) 752-1711
Executives
President, CEO, and Director
Glenn D. Bolduc
VP Finance
Roger P. Deschenes